United States · FDA National Drug Code directory
Paroxetine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62175-470_9474f942-d6d8-486b-8ea6-f8c561bb5014
- Product NDC
- 62175-470
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- Paroxetine Hydrochloride
- Labeler
- Lannett Company, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20141031
- Source listing expiry
- 20261231
Source-listed ingredients
- PAROXETINE HYDROCHLORIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62175-470-32) · 62175-470-32
- 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62175-470-41) · 62175-470-41
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →